Rare and Orphan Diseases

33-47 of 47

• 

  RestartResume

  Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges

  RestartResume

  Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges

  Global Oncology Academy

  Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges

  • 

    

    Gerard A. Silvestri MD, MS, Master FCCP

  • 

    

    Anurag Singh, MD

  • 

    

    Adam H. Fox, MD, MSc

  • 

    

    Mariam Alexander, MD, PhD

• 

  RestartResume

  From Diagnosis to Treatment: Challenges in Glioblastoma Care

  RestartResume

  From Diagnosis to Treatment: Challenges in Glioblastoma Care

  NeuroFrontiers

  From Diagnosis to Treatment: Challenges in Glioblastoma Care

  • 

    

    Lauren Schaff, MD

• 

  RestartResume

  Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy

  RestartResume

  Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy

  Project Oncology®

  Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy

• 

  RestartResume

  Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care

  RestartResume

  Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care

  Project Oncology®

  Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care

  • 

    

    Shaji K. Kumar, MD

• 

  RestartResume

  The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression

  RestartResume

  The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression

  Project Oncology®

  The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression

  • 

    

    Urvi A. Shah, MD, MS

• 

  RestartResume

  Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma

  RestartResume

  Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma

  Project Oncology®

  Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma

• 

  RestartResume

  Exercise in Multiple Myeloma: Balancing Benefits and Safety 

  RestartResume

  Exercise in Multiple Myeloma: Balancing Benefits and Safety 

  Project Oncology®

  Exercise in Multiple Myeloma: Balancing Benefits and Safety 

  • 

    

    Jens Hillengass, MD, PhD

• 

  RestartResume

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

  RestartResume

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

  Project Oncology®

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

• 

  RestartResume

  Diagnosing Castleman Disease: Key Considerations

  RestartResume

  Diagnosing Castleman Disease: Key Considerations

  Project Oncology®

  Diagnosing Castleman Disease: Key Considerations

  • 

    

    Mateo Bustamante

• 

  RestartResume

  Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells

  RestartResume

  Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells

  Project Oncology®

  Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells

  • 

    

    Joshua Brandstadter, MD, PhD, MSc

• 

  RestartResume

  Risk Stratification Models for Precursor Diseases in Multiple Myeloma

  RestartResume

  Risk Stratification Models for Precursor Diseases in Multiple Myeloma

  Project Oncology®

  Risk Stratification Models for Precursor Diseases in Multiple Myeloma

  • 

    

    Betsy O'Donnell, MD

• 

  RestartResume

  From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

  RestartResume

  From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

  Project Oncology®

  From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

  • 

    

    Betsy O'Donnell, MD

• 

  RestartResume

  Optimizing the Screening of Precursor Diseases in Multiple Myeloma

  RestartResume

  Optimizing the Screening of Precursor Diseases in Multiple Myeloma

  Project Oncology®

  Optimizing the Screening of Precursor Diseases in Multiple Myeloma

  • 

    

    Betsy O'Donnell, MD

• 

  RestartResume

  Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

  RestartResume

  Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

  Project Oncology®

  Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

  • 

    

    Matt Birnholz, MD

  • 

    

    Saad Kenderian M.B, Ch.B

• 

  RestartResume

  Genetic Research into Hypodiploid ALL

  RestartResume

  Genetic Research into Hypodiploid ALL

  Focus on Cancer

  Genetic Research into Hypodiploid ALL

  • 

    

    Bruce Bloom, DDS, JD

  • 

    

    Charles Mullighan, MBBS, MSc, MD

• Previous
• 1
• 2
• 3
• Next